| 000 | 01676 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513033155.0 | ||
| 264 | 0 | _c19951228 | |
| 008 | 199512s 0 0 eng d | ||
| 022 | _a0009-7322 | ||
| 024 | 7 |
_a10.1161/01.cir.92.11.3264 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScheinman, M M | |
| 245 | 0 | 0 |
_aDose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group. _h[electronic resource] |
| 260 |
_bCirculation _cDec 1995 |
||
| 300 |
_a3264-72 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmiodarone _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypotension _xchemically induced |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aTachycardia, Ventricular _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVentricular Fibrillation _xdrug therapy |
| 700 | 1 | _aLevine, J H | |
| 700 | 1 | _aCannom, D S | |
| 700 | 1 | _aFriehling, T | |
| 700 | 1 | _aKopelman, H A | |
| 700 | 1 | _aChilson, D A | |
| 700 | 1 | _aPlatia, E V | |
| 700 | 1 | _aWilber, D J | |
| 700 | 1 | _aKowey, P R | |
| 773 | 0 |
_tCirculation _gvol. 92 _gno. 11 _gp. 3264-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.cir.92.11.3264 _zAvailable from publisher's website |
| 999 |
_c7585754 _d7585754 |
||